McLean, E., Roo, C. D., Maag, A., Coble, M., Cano, J., & Liu, R. ERK1/2 Inhibition Alleviates Diabetic Cardiomyopathy by Suppressing Fatty Acid Metabolism. IMR Press.
Chicago Style (17th ed.) CitationMcLean, Erin, Caroline De Roo, Annabel Maag, Megan Coble, Jefferson Cano, and Ruijie Liu. ERK1/2 Inhibition Alleviates Diabetic Cardiomyopathy by Suppressing Fatty Acid Metabolism. IMR Press.
MLA (9th ed.) CitationMcLean, Erin, et al. ERK1/2 Inhibition Alleviates Diabetic Cardiomyopathy by Suppressing Fatty Acid Metabolism. IMR Press.
Warning: These citations may not always be 100% accurate.